Google DeepMind’s Ambitious Vision for Drug Discovery Faces Scrutiny
At Google I/O, Demis Hassabis articulated a vision for AI in drug discovery that promises to tackle all diseases. Critics highlight the need for nuanced understanding amid the hype.
More from this archive
Bristol-Myers Squibb Partners with Anthropic for AI-Driven Drug Discovery
Bristol-Myers Squibb announces a strategic partnership with Anthropic to leverage AI for improved drug discovery, impacting over 30,000…
Bristol Myers Squibb Partners with Anthropic to Boost Drug Discovery
Bristol Myers Squibb has partnered with Anthropic to deploy the Claude AI model across its workforce, aiming to…
SandboxAQ Enhances Drug Discovery with Anthropic’s Claude Integration
SandboxAQ's integration of LQMs with Anthropic's Claude promises to accelerate drug discovery and materials science by simplifying user…
DeepMind and Edison Push Boundaries with AI Scientist Platforms
Google DeepMind and Edison Scientific are developing AI platforms that could significantly speed up biomedical research, promising to…
The archive
sorted by latest
New AI Partnership Streamlines Drug Discovery via Conversational Interfaces
GPUBeat Desk · 2 min
SandboxAQ Enhances Anthropic’s Claude Chatbot for Drug Discovery
GPUBeat Desk · 2 min
SandboxAQ Integrates Scientific AI Models with Anthropic’s Claude
GPUBeat Desk · 2 min
SandboxAQ Partners with Anthropic to Enhance Access to AI Models
GPUBeat Desk · 2 min
SandboxAQ Streamlines Drug Discovery with Anthropic’s Claude Integration
GPUBeat Desk · 2 min